LEXICON
No.104 March 5, 2012

Japan Pharmaceutical Political Association
日本薬業政治連盟
Seiyaku Sangyo Seiji Renmei
製薬産業政治連盟

The Japan Pharmaceutical Political Association (日本薬業政治連盟) was created in 1982 as a political arm of the Federation of Japan Pharmaceutical Wholesalers Associations (JPWA;日本医薬品卸業連合会). It provides active support to lawmakers to enhance wholesalers’ profile in recognition of the fact that wholesalers...

To read the full story

LEXICON

By Izuru Ando

While Japan has now granted its first emergency approval to Shionogi’s COVID-19 pill Xocova (ensitrelvir), the drug failed to win a unanimous vote by advisory panels, with skepticism lingering over its actual efficacy. To prep for the next emergency, which…

By Philip Carrigan

As the year 2022 draws to a close, what are managers thinking at the world’s leading pharmaceutical companies and medical device companies? We surveyed 86 managers at these companies to find out what’s on their minds.For many managers, a common…

A Japanese reimbursement policy panel on November 16 saw a continued scuffle between members representing healthcare providers and payers over…

Deloitte Tohmatsu Consulting proposed three drug pricing schemes designed to trigger the consolidation of generic makers on October 27, offering…

Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…

Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…